Mark S. Shearman, Chief Scientific Officer at APPLIED GENETIC TECHNOLOGIES CORP (AGTC), sold 3,000 shares at $3.35 ($10K) on 2018-12-14, disclosed to the SEC on 2018-12-18.
Open-market sale of $10k AGTC by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AGTC | BUY | 2016-09-26 | $27K | — | Filing → |